首页 | 本学科首页   官方微博 | 高级检索  
     


Myocardial perfusion,oxidative metabolism,and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp 175Asn mutation in the α-tropomyosin gene: A positron emission tomography study
Authors:Helena Tuunanen  Johanna Kuusisto  Jyri Toikka  Pertti Jääskeläinen  Päivi Marjamäki  Keijo Peuhkurinen  Tapio Viljanen  Petri Sipola  Kira Q. Stolen  Jarna Hannukainen  Pirjo Nuutila  Markku Laakso  Juhani Knuuti
Affiliation:(1) Turku PET Centre, PO Box 52, FIN-20521 Turku, Finland;(2) Department of Clinical Physiology, Tampere University Hospital, Tampere;(3) Department of Medicine, Kuopio University Hospital, Kuopio, Finland;(4) Department of Medicine Clinical Radiology, Kuopio University Hospital, Kuopio, Finland
Abstract:Background  The relationship between myocardial metabolic changes and the severity of left ventricular (LV) hypertrophy in patients with hypertrophic cardiomyopathy (HCM) is largely unknown. We characterized metabolic abnormalities in patients with a genetically identical cause for HCM but with variable LV hypertrophy. Methods and Results  Eight patients with HCM attributable to the Asp175Asn mutation in the α-tropomyosin gene underwent myocardial perfusion, oxidative, and free fatty acid (FFA) metabolism measurements via positron emission tomography and oxygen 15-labeled water, carbon 11 acetate, and fluorine 14(R,S)-[18F] Fluoro-6-thia-heptadecanoic acid (18 FTHA). LV mass, work, and efficiency were assessed by echocardiography. Thirty-six healthy volunteers served as control subjects. Compared with control subjects, HCM patients had increased myocardial oxidative metabolism and FFA uptake (P<.05). However, in patients, LV mass was inversely related to global myocardial perfusion, oxidative metabolism, and FFA uptake (all P<.03), and regional wall thickness was inversely related to regional perfusion (P<.01), oxidative metabolism (P<.001), and FFA uptake (P<.01). Therefore patients with mild (LV mass less than median of 177 g) but not advanced LV hypertrophy were characterized by increased perfusion, oxidative metablism, and LV efficiency as compared with control subjects (P<.05). Conclusions  In HCM attributable to the Asp 175Asn mutation in the α-tropomyosin gene, myocardial oxidative metabolism and FFA metabolism are increased and inversely related to LV hypertrophy at both the whole heart and regional level. Increased metabolism and efficiency characterize patients with mild myocardial hypertrophy. These hypermetabolic alterations regress with advanced hypertrophy. Dis Tuunanen and Kuusisto contributed equally to this work This study was financially supported by an EVO grant (Kuopio University Hospital), as well as the Turunen Foundation, Instrumentarium Foundation, and Finish Cultural Foundation.
Keywords:Hypertrophic cardiomyopath  myocardial metabolism  positron emission tomography  efficiency
本文献已被 ScienceDirect SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号